Cargando…
Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator
Continuous manufacturing is becoming the new technological standard in the pharmaceutical industry. In this work, a twin-screw processor was employed for the continuous production of liquisolid tablets containing either simethicone or a combination of simethicone with loperamide hydrochloride. Both...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142538/ https://www.ncbi.nlm.nih.gov/pubmed/37111750 http://dx.doi.org/10.3390/pharmaceutics15041265 |
_version_ | 1785033636723032064 |
---|---|
author | Zakowiecki, Daniel Richter, Margarethe Yuece, Ceren Voelp, Annika Ries, Maximilian Papaioannou, Markos Edinger, Peter Hess, Tobias Mojsiewicz-Pieńkowska, Krystyna Cal, Krzysztof |
author_facet | Zakowiecki, Daniel Richter, Margarethe Yuece, Ceren Voelp, Annika Ries, Maximilian Papaioannou, Markos Edinger, Peter Hess, Tobias Mojsiewicz-Pieńkowska, Krystyna Cal, Krzysztof |
author_sort | Zakowiecki, Daniel |
collection | PubMed |
description | Continuous manufacturing is becoming the new technological standard in the pharmaceutical industry. In this work, a twin-screw processor was employed for the continuous production of liquisolid tablets containing either simethicone or a combination of simethicone with loperamide hydrochloride. Both active ingredients present major technological challenges, as simethicone is a liquid, oily substance, and loperamide hydrochloride was used in a very small amount (0.27% w/w). Despite these difficulties, the use of porous tribasic calcium phosphate as a carrier and the adjustment of the settings of the twin-screw processor enabled the optimization of the characteristics of the liquid-loaded powders and made it possible to efficiently produce liquisolid tablets with advantages in physical and functional properties. The application of chemical imaging by means of Raman spectroscopy allowed for the visualization of differences in the distribution of individual components of the formulations. This proved to be a very effective tool for identifying the optimum technology to produce a drug product. |
format | Online Article Text |
id | pubmed-10142538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101425382023-04-29 Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator Zakowiecki, Daniel Richter, Margarethe Yuece, Ceren Voelp, Annika Ries, Maximilian Papaioannou, Markos Edinger, Peter Hess, Tobias Mojsiewicz-Pieńkowska, Krystyna Cal, Krzysztof Pharmaceutics Article Continuous manufacturing is becoming the new technological standard in the pharmaceutical industry. In this work, a twin-screw processor was employed for the continuous production of liquisolid tablets containing either simethicone or a combination of simethicone with loperamide hydrochloride. Both active ingredients present major technological challenges, as simethicone is a liquid, oily substance, and loperamide hydrochloride was used in a very small amount (0.27% w/w). Despite these difficulties, the use of porous tribasic calcium phosphate as a carrier and the adjustment of the settings of the twin-screw processor enabled the optimization of the characteristics of the liquid-loaded powders and made it possible to efficiently produce liquisolid tablets with advantages in physical and functional properties. The application of chemical imaging by means of Raman spectroscopy allowed for the visualization of differences in the distribution of individual components of the formulations. This proved to be a very effective tool for identifying the optimum technology to produce a drug product. MDPI 2023-04-18 /pmc/articles/PMC10142538/ /pubmed/37111750 http://dx.doi.org/10.3390/pharmaceutics15041265 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zakowiecki, Daniel Richter, Margarethe Yuece, Ceren Voelp, Annika Ries, Maximilian Papaioannou, Markos Edinger, Peter Hess, Tobias Mojsiewicz-Pieńkowska, Krystyna Cal, Krzysztof Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator |
title | Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator |
title_full | Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator |
title_fullStr | Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator |
title_full_unstemmed | Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator |
title_short | Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator |
title_sort | towards the continuous manufacturing of liquisolid tablets containing simethicone and loperamide hydrochloride with the use of a twin-screw granulator |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142538/ https://www.ncbi.nlm.nih.gov/pubmed/37111750 http://dx.doi.org/10.3390/pharmaceutics15041265 |
work_keys_str_mv | AT zakowieckidaniel towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator AT richtermargarethe towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator AT yuececeren towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator AT voelpannika towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator AT riesmaximilian towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator AT papaioannoumarkos towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator AT edingerpeter towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator AT hesstobias towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator AT mojsiewiczpienkowskakrystyna towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator AT calkrzysztof towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator |